[Rhabdomyolysis during treatment with rabeprazole (Pariel), a proton pump inhibitor combined with domperidone (Peridys)].
Bourlon
S
S
Veyrac
G
G
Armand
C
C
Lambert
O
O
Bourin
M
M
Jolliet
P
P
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents / Q000009:adverse effects*; D000932:Antiemetics / Q000009:adverse effects*; D001562:Benzimidazoles / Q000009:adverse effects*; D004294:Domperidone / Q000009:adverse effects*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D008875:Middle Aged; D009853:Omeprazole / Q000031:analogs & derivatives; D064750:Rabeprazole; D012206:Rhabdomyolysis / Q000139:chemically induced*
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D000932:Antiemetics; D001562:Benzimidazoles; D064750:Rabeprazole; D004294:Domperidone; D009853:Omeprazole